METTL3 and hepatocellular carcinoma: To further investigate the effect of METTL3 O-GlcNAcylation on HCC progression, we synthesized candidate peptides CPPtat-M1/M2 based on the identified O-GlcNAcylation motif of METTL3 (179–203) to inhibit this modification (Fig. 7A).